Cryo-Cell International, Inc. and U.S. Bank Trust Company, National Association, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of [May , 2022] to the Indenture dated as of [May , 2022] [ ]% Senior Notes due [20 ]Cryo Cell International Inc • April 28th, 2022 • Services-misc health & allied services, nec • New York
FIRST SUPPLEMENTAL INDENTURE (this “First Supplemental Indenture”), dated as of [May , 2022], between Cryo-Cell International, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).
CRYO-CELL INTERNATIONAL, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 28th, 2022 • Cryo Cell International Inc • Services-misc health & allied services, nec • New York
Cryo-Cell International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters on Schedule A hereto (the “Underwriters”), for whom Ladenburg Thalmann & Co. Inc. is acting as representative (in such capacity, the “Representative”), $[ ],000,000 aggregate principal amount of [ ]% Senior Notes due 202[ ] (the “Firm Notes”). In addition, the Company proposes to grant to the Underwriters the option to purchase from the Company up to an additional $[ ],000,000 aggregate principal amount of [ ]% Senior Notes due 2026 (the “Additional Notes”). The Firm Notes and, if and to the extent such option is exercised, the Additional Notes are hereinafter collectively referred to as the “Notes.”
